MACC1 and neoplasm: High MACC1 expression levels, whether determined in the primary tumor or in the cancer patient’s blood, predict a reduced survival time, caused by a promotion of tumor aggressiveness and metastasis formation, even when detected in early, not yet metastasized tumor stages [6].